The average suggested dose of Sildenafil Citrate is 50 mg. For males that do not respond sufficiently to this amount, the dosage might be greater up to 100 mg or decreased to 25 mg. The medication is taken roughly one hour prior to sexual activity is planned, and might remain effective for more than four hours.  While it is safe to take there are some significant side effects to taking Sildenafil Citrate

The mechanism of action of Sildenafil involves the ejection of nitric oxide (NO) in the corpus cavernosum of the male genitals. NO binds to the receptors of the enzyme guanylate cyclase which leads to greater levels of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation (vasodilation) of the intimal cushions of the helicine arteries, resulting in greater inflow of blood and an erection. Robert F. Furchgott won the Nobel Prize in Physiology or Medicine in 1998 for his discovery and analysis of endothelium-derived relaxing factor, a key part of the NO mechanism of action.

A different investigational study set up by researchers at Johns Hopkins University School of Medicine in Baltimore, and published in the August 2000 issue of the Journal of Clinical Investigation found that Sildenafil Citrate could possibly have added clinical promise for people with diabetes beyond treating ED. In animal studies, Sildenafil Citrate was effective in relaxing the pyloric muscle of stomach, improving digestion and relieving the issues of gastroparesis. Up to 75% of people with diabetes are suffering from from gastroparesis, which causes bloating, nausea, loss of appetite, and vomiting. Further human studies are needed to evaluate Sildenafil Citrate ’s useability in treating this usual diabetic complication.

Those experiencing heart function issues including dizziness, chest or arm pain, and nausea when participating in sexual activity after taking Sildenafil Citrate may stop immediately. As well as this they may also not take Sildenafil Citrate again until they have discussed the side effects episode with their healthcare provider.

Sildenafil was originally developed in the early 90’s as a medication for angina, or chest pain. The medication, marketed under the name Sildenafil Citrate , taken FDA sell clearance as a treattfor impotence in March 1998, and since then it has been prescribed for over 10 million males worldwide. It was the initial oral medication given approval for ED deal withmalest. A newer medication, tadalafil, has been developed to deal with males who do not respond to sildenafil citrate. Tadalafil has gained preliminary approval in the European Union (EU), and is in the final stages of regulatory approval in Canada as of November 2002.

As well as E.D., sildenafil citrate is also effective in the unusual disease pulmonary arterial hypertension (PAH). It relaxes the arterial wall, leading to decreased pulmonary arterial resistance and pressure. This in turn lessens the workload of the right ventricle of the heart and increases issues of right-sided heart failure.
The average suggested dose of Sildenafil Citrate is 50 mg. For males that do not respond sufficiently to this amount, the dosage might be greater up to 100 mg or decreased to 25 mg. The medication is taken roughly one hour prior to sexual activity is planned, and might remain effective for more than four hours.

The mechanism of action of Sildenafil involves the ejection of nitric oxide (NO) in the corpus cavernosum of the male genitals. NO binds to the receptors of the enzyme guanylate cyclase which leads to greater levels of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation (vasodilation) of the intimal cushions of the helicine arteries, resulting in greater inflow of blood and an erection. Robert F. Furchgott won the Nobel Prize in Physiology or Medicine in 1998 for his discovery and analysis of endothelium-derived relaxing factor, a key part of the NO mechanism of action.

A different investigational study set up by researchers at Johns Hopkins University School of Medicine in Baltimore, and published in the August 2000 issue of the Journal of Clinical Investigation found that Sildenafil Citrate could possibly have added clinical promise for people with diabetes beyond treating ED. In animal studies, Sildenafil Citrate was effective in relaxing the pyloric muscle of stomach, improving digestion and relieving the issues of gastroparesis. Up to 75% of people with diabetes are suffering from from gastroparesis, which causes bloating, nausea, loss of appetite, and vomiting. Further human studies are needed to evaluate Sildenafil Citrate ’s useability in treating this usual diabetic complication.

Those experiencing heart function issues including dizziness, chest or arm pain, and nausea when participating in sexual activity after taking Sildenafil Citrate may stop immediately. As well as this they may also not take Sildenafil Citrate again until they have discussed the episode with their healthcare provider.

Sildenafil was originally developed in the early 90’s as a medication for angina, or chest pain. The medication, marketed under the name Sildenafil Citrate , taken FDA sell clearance as a treattfor impotence in March 1998, and since then it has been prescribed for over 10 million males worldwide. It was the initial oral medication given approval for ED deal withmalest. A newer medication, tadalafil, has been developed to deal with males who do not respond to sildenafil citrate. Tadalafil has gained preliminary approval in the European Union (EU), and is in the final stages of regulatory approval in Canada as of November 2002.

As well as E.D., sildenafil citrate is also effective in the unusual disease pulmonary arterial hypertension (PAH). It relaxes the arterial wall, leading to decreased pulmonary arterial resistance and pressure. This in turn lessens the workload of the right ventricle of the heart and increases issues of right-sided heart failure.
The average suggested dose of Sildenafil Citrate is 50 mg. For males that do not respond sufficiently to this amount, the dosage might be greater up to 100 mg or decreased to 25 mg. The medication is taken roughly one hour prior to sexual activity is planned, and might remain effective for more than four hours.

The mechanism of action of Sildenafil involves the ejection of nitric oxide (NO) in the corpus cavernosum of the male genitals. NO binds to the receptors of the enzyme guanylate cyclase which leads to greater levels of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation (vasodilation) of the intimal cushions of the helicine arteries, resulting in greater inflow of blood and an erection. Robert F. Furchgott won the Nobel Prize in Physiology or Medicine in 1998 for his discovery and analysis of endothelium-derived relaxing factor, a key part of the NO mechanism of action.

A different investigational study set up by researchers at Johns Hopkins University School of Medicine in Baltimore, and published in the August 2000 issue of the Journal of Clinical Investigation found that Sildenafil Citrate could possibly have added clinical promise for people with diabetes beyond treating ED. In animal studies, Sildenafil Citrate was effective in relaxing the pyloric muscle of stomach, improving digestion and relieving the issues of gastroparesis. Up to 75% of people with diabetes are suffering from from gastroparesis, which causes bloating, nausea, loss of appetite, and vomiting. Further human studies are needed to evaluate Sildenafil Citrate ’s useability in treating this usual diabetic complication.

Those experiencing heart function issues including dizziness, chest or arm pain, and nausea when participating in sexual activity after taking Sildenafil Citrate may stop immediately. As well as this they may also not take Sildenafil Citrate again until they have discussed the episode with their healthcare provider.

Sildenafil was originally developed in the early 90’s as a medication for angina, or chest pain. The medication, marketed under the name Sildenafil Citrate , taken FDA sell clearance as a treattfor impotence in March 1998, and since then it has been prescribed for over 10 million males worldwide. It was the initial oral medication given approval for ED deal withmalest. A newer medication, tadalafil, has been developed to deal with males who do not respond to sildenafil citrate. Tadalafil has gained preliminary approval in the European Union (EU), and is in the final stages of regulatory approval in Canada as of November 2002.

As well as E.D., sildenafil citrate is also effective in the unusual disease pulmonary arterial hypertension (PAH). It relaxes the arterial wall, leading to decreased pulmonary arterial resistance and pressure. This in turn lessens the workload of the right ventricle of the heart and increases issues of right-sided heart failure.
The average suggested dose of Sildenafil Citrate is 50 mg. For males that do not respond sufficiently to this amount, the dosage might be greater up to 100 mg or decreased to 25 mg. The medication is taken roughly one hour prior to sexual activity is planned, and might remain effective for more than four hours.

The mechanism of action of Sildenafil involves the ejection of nitric oxide (NO) in the corpus cavernosum of the male genitals. NO binds to the receptors of the enzyme guanylate cyclase which leads to greater levels of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation (vasodilation) of the intimal cushions of the helicine arteries, resulting in greater inflow of blood and an erection. Robert F. Furchgott won the Nobel Prize in Physiology or Medicine in 1998 for his discovery and analysis of endothelium-derived relaxing factor, a key part of the NO mechanism of action.

A different investigational study set up by researchers at Johns Hopkins University School of Medicine in Baltimore, and published in the August 2000 issue of the Journal of Clinical Investigation found that Sildenafil Citrate could possibly have added clinical promise for people with diabetes beyond treating ED. In animal studies, Sildenafil Citrate was effective in relaxing the pyloric muscle of stomach, improving digestion and relieving the issues of gastroparesis. Up to 75% of people with diabetes are suffering from from gastroparesis, which causes bloating, nausea, loss of appetite, and vomiting. Further human studies are needed to evaluate Sildenafil Citrate ’s useability in treating this usual diabetic complication.

Those experiencing heart function issues including dizziness, chest or arm pain, and nausea when participating in sexual activity after taking Sildenafil Citrate may stop immediately. As well as this they may also not take Sildenafil Citrate again until they have discussed the episode with their healthcare provider.

Sildenafil was originally developed in the early 90’s as a medication for angina, or chest pain. The medication, marketed under the name Sildenafil Citrate , taken FDA sell clearance as a treattfor impotence in March 1998, and since then it has been prescribed for over 10 million males worldwide. It was the initial oral medication given approval for ED deal withmalest. A newer medication, tadalafil, has been developed to deal with males who do not respond to sildenafil citrate. Tadalafil has gained preliminary approval in the European Union (EU), and is in the final stages of regulatory approval in Canada as of November 2002.

As well as E.D., sildenafil citrate is also effective in the unusual disease pulmonary arterial hypertension (PAH). It relaxes the arterial wall, leading to decreased pulmonary arterial resistance and pressure. This in turn lessens the workload of the right ventricle of the heart and increases issues of right-sided heart failure.